Cytochrome P450 BM-3 variant 139-3 is highly active in the hydroxylation of alkanes and fatty acids (A Glieder, ET Farinas, and FH Arnold, Nature Biotech 2002;20:1135-1139; it also epoxidizes various alkenes, including styrene. Here the authors describe a colorimetric, high-throughput assay suitable for optimizing this latter activity by directed evolution. The product of styrene oxidation by 139-3, styrene oxide, reacts with the nucleophile γ-(4-nitrobenzyl)pyridine (NBP) to form a purplecolored precursor dye, which can be monitored spectrophotometrically in cell lysates. The sensitivity limit of this assay is 50-100 µM of product, and the detection limit for P450 BM-3 139-3 is~0.2 µM of enzyme. To validate the assay, activities in a small library of random mutants were compared to those determined using an NADPH depletion assay for initial turnover ratesJournal of Biomolecular Screening 9(2); 2004 www.sbsonline.org 143 FIG. 1. Alkene oxidation turnover rates for P450 BM-3 wild-type (black bars) and variant 139-3 (gray bars). Colorimetric High-Throughput Assay Journal of Biomolecular Screening 9(2); 2004 www.sbsonline.org 145 FIG. 5. Activities of clones from the library of BM-3 139-3 mutants prepared by error-prone PCR, plotted in descending order. (A) NADPH depletion assay. (B) NBP endpoint assay. Solid horizontal lines show activity of the parent (139-3) in the assay. Dashed lines indicate the coefficient of variation of the assays (15%-18%).
INTRODUCTION
E POXIDES ARE USEFUL CHIRAL INTERMEDIATES of significance for chemical synthesis due to their wide versatility. The preparation of such compounds (particularly in enantiopure form) has been an important goal over the past decade, essentially because of the growing demand for optically active compounds for pharmaceuticals' synthesis. Epoxides are also being used for the synthesis of cosmetics, surfactants, industrial sterilants, and fumigants. 1, 2 Although new approaches to preparing epoxides by chemical catalysis have been described, [1] [2] [3] [4] the shortcomings include poor catalytic efficiencies, particularly for epoxidation of trans olefins, and high costs, among others. Biocatalysts offer the possibility of working under mild conditions and with high selectivities. Biocatalytic routes suggested for epoxide synthesis include direct epoxidation of alkenes using peroxidases or monooxygenases and resolution of racemic mixtures using epoxide hydrolases. 5 Esterases and lipases are widely used in the resolution of epoxide precur-sors, such as halohydrins. 6, 7 The main bottlenecks of biocatalysis in the production of epoxides are the low turnover rates, instability of the precursors, enzyme inactivation by reaction with the epoxide products, and the catalysts'dependence on redox partners.
A biocatalyst candidate for direct oxidation of alkenes is cytochrome P450 BM-3 from Bacillus megaterium. This heme enzyme, which inserts oxygen into subterminal C-H bonds of fatty acids (C12-C18), is a natural fusion protein containing the reductase domain and the heme domain in the same polypeptide chain (118 kDa). 8 This highly active enzyme is soluble, reasonably stable, and easily expressed in Escherichia coli, all of which make it attractive for industrial applications. In previous work, we converted this fatty acid monoxygenase into a highly efficient catalyst for the conversion of alkanes to alcohols, using directed evolution. 9 The evolved alkane hydroxylase (P450 BM-3 139-3) has also been found to be active toward alkenes. 10 Activities and coupling efficiencies, however, are rather low and would need to be improved before this enzyme would become synthetically useful.
Spectrophotometric methods for measuring epoxide concentrations in assays of hydrolases have been reported. [11] [12] [13] However, none of these protocols can be used to screen mutant libraries of cytochrome P450s for olefin epoxidation, because the detection limits are too high (millimolar range). 11 Typically when an enzyme is evolved for a new substrate specificity, only small amounts of product are expected in the initial rounds of evolution, and a sensitive assay capable of detecting micromolar quantities is needed. Furthermore, the dioxygen content of air-saturated water is approximately 250 µM, and dioxygen is a limiting reagent. Thus, the detection threshold of the published assays cannot be satisfied. Here we describe a sensitive, high-throughput screening (HTS) as-say suitable for directed evolution of P450 BM-3 139-3 (and other biocatalysts) to improve alkene epoxidation. The method could also be used to screen microbial cultures for alkene epoxidation activity. The method is based on the epoxidation of styrene by P450 BM-3 139-3 and the corresponding reaction between styrene oxide and γ-(4-nitrobenzyl)pyridine (NBP). 14 
MATERIAL
Max Efficiency DH5α Competent Cells were from Invitrogen (Carlsbad, CA). All chemicals were of analytical reagent grade or higher quality and were purchased from Fluka (Ronkonkoma, NY), Aldrich (Milwaukee, WI), or Sigma (St. Louis, MO) except isopropyl-δ-D-thiogalactopyranoside from ICN (Aurora, OH). Enzymes were purchased from New England Biolabs (Beverly, MA), Stratagene (La Jolla, CA), and Boehringer (Mannheim, Germany).
METHODS

Production of P450 BM-3 139-3
The P450 BM-3 139-3 gene was cloned behind the double tac promoter of the expression vector pCWori (pBM3_WT18-6). 9 For enzyme production, supplemented terrific broth (TB) medium 15 (500 ml) was inoculated with 500 µl of an overnight culture of E. coli DH5α containing the expression plasmid. After shaking for 10 h at 35°C and 250 rpm, the heme precursor δ-aminolevulinic acid hydrochloride (ALA, 0.5 mM) was added, and the expression was induced by the addition of isopropyl-β-D-thiogalactoside (IPTG, 1 mM). The cells were cultivated for 30 h at 30°C. The enzyme was purified as described, 15 and the enzyme concentration was determined from the CO-difference spectra. 16 
Determination of maximum initial rates of NADPH consumption
Initial rates were determined based on NADPH consumption rates in the presence of substrate. 17 A typical reaction solution contained purified enzyme (1.0 ml, 1.0 µM) in phosphate buffer (0.1 M, pH 8.0), substrate (2 mM), and methanol (1% v/v). The reaction was initiated by the addition of NADPH (200 µl, 200 µM), and the absorption at 340 nm was monitored using a UV-Vis spectrophotometer and 1 cm pathlength quartz cuvettes. A blank without alkene was performed to determine background consumption of NADPH.
Monitoring H 2 O 2 production
Hydrogen peroxide concentrations were measured using the 2,2′-azino-di-[3-ethyl-benzothiazidine]-6-sulfonic acid (ABTS)horseradish peroxidase (HRP) assay according to published procedures, 18 with minor modifications. Reaction mixture (1 ml) was incubated with 100 µl of 1 N HCl to stop the reaction. The sample was neutralized with 100 µl 1 N NaOH. Afterward, 100 µl 10 mM ABTS were introduced, followed by the addition of 5 µl of 5 mg/ ml HRP. A calibration curve from 0 to 500 nM H 2 O 2 was prepared. The amount of oxidized ABTS was measured at 406 nm.
Random mutagenesis
A library of random mutants of cytochrome P450 BM-3 variant 139-3 was created by error-prone PCR, using the Genemorph kit (Stratagene) according to the manufacturer's protocol for a low mutation rate (10-100 ng of template DNA). The primers used for amplification were Bamfor (5′-acaggatccatcgatgcttaggaggtcatatg-3′) and Sacrev (5′-gtgaaggaataccgccaag-3′). The PCR product was cloned by replacing the BamHI-SacI fragment of pBM3_WT18-6. 9
Preparation of cell lysates for high-throughput screening
DH5α cells were transformed with the plasmid containing the parent 139-3 gene or the library created by error-prone PCR, plated on Luria-Bertani (LB) agar containing ampicillin (100 mg/ l), and grown for~24 h at 37°C. Individual colonies were picked into 1 ml deep-well plates containing LB medium (0.3 ml) and ampicillin (100 mg/l). The plates were incubated at 30°C, with shaking at 250 rpm and 80% relative humidity (Humidity shaker model ISF-1-W, Kuhner, Farmingdale, NY). After 24 h, clones from this preculture were inoculated using a 96 replicator pin into 2 ml deep-well plates with TB medium (400 µl) containing ampicillin (100 mg/l), trace elements (250 µl/l), thiamine (100 mg/ ml), IPTG (10 µM), and ALA (0.5 mM). Trace elements composition: 0.5 g MgCl 2 , 30.0 g FeCl 2 6H 2 O, 1.0 g ZnCl 2 4H 2 0, 0.2 g CoCl 2 6H 2 O, 1.0 g Na 2 MoO 4 2H 2 O, 0.5 g CaCl 2 2H 2 O, 1.0 g CuCl 2 , and 0.2 g H 2 BO 3 in 1 L HCl solution (90% v/v distilled water: concentrated HCl). 15 The clones were cultivated at 30°C for 24-30 h. The plates were centrifuged at 2300 g, the medium was discarded, and the cell pellets were frozen at -20°C. The frozen cell pellets were resuspended in phosphate buffer (0.4 ml, 0.1 M, pH 8.0) containing lysozyme (0.25 mg/ml), DNase I (1.5 U/ml), and MgCl 2 (10 mM). After 60 min at 37°C, the lysates were centrifuged at 2300 g, and the supernatant was used for activity measurements in 96-well microtiter plates.
HIGH-THROUGHPUT ASSAYS
Product formation assay: NBP-endpoint assay
Ten µl of cleared lysate was transferred to a 96-well microtiter plate (R-96-OAPF-1CO microplates, from Rainin) containing 70 µl phosphate buffer (0.1 M, pH 8.0) and 10 µl styrene (100 mM in methanol). The reaction was initiated by the addition of 10 µl NADPH (20 mM in phosphate buffer 0.1 M, pH 8.0). The final concentrations in the reaction mixture were 10 mM styrene, 2 mM NADPH, and 10% methanol. The plate was shaken and incubated at room temperature for 5 min. Next, 25 µl NBP solution (stock: 0.4 g in 10 ml ethanol) was added, and the plate was shaken and sealed (Sealplate tape T-3021-7, from GeneMate). The plate was heated in an oven at 80°C for 30 min and afterward chilled on ice for 10 min. The film was removed, and 150 µl dimethylformamyde (DMF) and 25 µl 1M K 2 CO 3 were added in rapid succession. The plate was shaken again, and the absorbance at 600 nm was immediately measured with a plate reader (Spectra Max Plus 383, Molecular Devices, Sunnyvale, CA). Under these conditions, the microtiter plate remained transparent and etching was not observed. To validate the assay, a styrene oxide calibration curve was prepared using conditions as in the reaction protocol, with styrene oxide added to the solution (from 0 to 500 µM) in place of styrene. The final mixture contained 2 mM NADPH, 10% methanol, 10% cleared lysate, and a known amount of styrene oxide. After shaking the plate, 25 µl NBP solution (stock: 0.4 g in 10 ml ethanol) was added, and the remaining steps of the assay were performed as described above. Each point was done in triplicate.
NADPH depletion assay
A cofactor (NADPH) depletion assay was used to determine initial rates of reaction. 17 E. coli lysates (20 µl) were diluted into 96-well microplates containing 130 µl phosphate buffer (0.1 M, pH 8.0) and 2 µl styrene (100 mM in methanol). The reaction was started by addition of 80 µl NADPH (0.626 mM in phosphate buffer 0.1 M, pH 8.0), and oxidation of NADPH was monitored at 340 nm. A blank without styrene was performed for each plate to determine the NADPH background consumption rate.
RESULTS AND DISCUSSION
Cytochrome P450 BM-3 variant 139-3 catalyzes the hydroxylation of various alkanes and fatty acids at high rates. 9 Because it is so broadly active, we decided to examine this enzyme's ability to catalyze the epoxidation of alkenes, using an array of aliphatic and aromatic substrates (Fig. 1) . The initial rate of NADPH oxidation evaluated for 139-3 surpasses that of wild-type BM3, on all the substrates tested. NADPH oxidation is not necessarily an accurate measure of activity in alkene epoxidation, because electron equivalents from NADPH can be diverted to produce reduced oxygen species (H 2 O or H 2 O 2 ). This process is referred to as "uncoupling." As determined by the ABTS/HRP assay, less than 1.6% of the NADPH is diverted to production of H 2 O 2 for the substrates shown in Figure 1 (data not shown). Gas chromatography/mass spectrometry (GC/MS) analysis of the reaction products, however, revealed that styrene oxidation by 139-3 yields styrene oxide, with a coupling efficiency of only~35%. 10 Due to the uncoupling of cofactor oxidation from product forma-tion, use of a cofactor depletion assay can be risky for directed evolution of a more efficient epoxidation biocatalyst.
Styrene was selected as substrate for developing a highthroughput assay that is sensitive to epoxide product formation. As reported previously, [19] [20] [21] NBP reacts with epoxides to form a purple dye in alkaline or acid media. The unpaired electrons from the pyridine ring of NBP act as a nucleophilic agent, which attacks the oxirane ring of styrene oxide to yield a purple chromophore (Fig.  2) . We have developed a version of this endpoint assay that is suitable for directed evolution or for identifying epoxidation biocatalysts in complex media. It is sufficiently sensitive to detect the activity of P450 BM3 variant 139-3 expressed in E. coli, is reproducible, and can be used in cell lysates.
In developing the assay, we first evaluated the relationship between the absorbance and styrene oxide concentration from a fresh stock solution of styrene oxide (Fig. 3) . The curve was prepared in the presence of lysed cells in order to reproduce the assay conditions (see Methods section). The presence of lysate in the assay increased the absorbance from 0 to 0.3-0.4. A linear relation between the amount of styrene oxide under reaction conditions and absorbance was found. The sensitivity limit of this colorimetric assay is 50-100 µM of product.
Because variant 139-3 displays a high rate of NADPH consumption, dioxygen is quickly consumed during the reaction, and its availability quickly becomes rate-limiting. Figure 4 illustrates the result of increasing the enzyme concentration under the reaction conditions described in the Methods section. Indeed, substrate conversion reaches a plateau when the enzyme concentration is~2 µM. However, from~0.1 to 0.8 µM of enzyme, the assay is sensitive to small changes in enzyme concentration (and therefore in activity). The detection limit for P450 BM-3 139-3 is~0.2 µM of enzyme.
After biotransformation, it is necessary to dissolve the product in DMF to develop a homogeneous color mixture. The final mix-ture is stable for at least 20 min at room temperature (longer at 4°C and in the dark). Nevertheless, the measurement of the absorbance immediately after color development is imperative, as the final color fades with time. Good reproducibility is obtained following the procedure provided above.
To validate the assay, a test plate containing 139-3 in the different wells was prepared. E. coli cells were transformed with the plasmid containing the 139-3 gene and plated on LB/amp plates. The activities of the different clones were evaluated from fresh lysate preparations, as described in the Methods section. The coefficients of variation (CV) for the NBP-endpoint and NADPH depletion assays were 18% and 15%, respectively.
The assay was then used to characterize a small library of mutants (about 600 clones) created using error-prone PCR. The random mutagenesis conditions were set to introduce 1-2.5 mutations per Kb. Figure 5 shows the results of the NBP-endpoint assay and the NADPH depletion assay, plotted in "landscape" form, in order of decreasing activity. The NADPH depletion assay measures the initial rate of substrate oxidation, whereas the NBP assay detects the amount of epoxide formed. The reactions conditions were optimized for each assay and differ from one another. For example, the amount of NADPH added to the NADPH depletion assay was near the detection limit of the NBP assay. In contrast, the initial amount of NADPH ([NADPH] i = 2 mM) added in the NBP assay was out of the linear range for accurate measurement of NADPH oxidation.
Approximately 200 clones were inactivated by the mutagenesis, and the data were largely consistent for the 2 assay methods. As might be expected, the NBP assay based on product formation gave no activity for some number of clones (~25) that were active in NADPH depletion (uncoupling). Both assays show evidence that activity toward styrene epoxidation can be enhanced by mutagenesis, although no highly active clones were identified from this small set of mutants (approximately 1000-3000 clones are screened in a typical generation of directed evolution). 22 NBP reacts spontaneously with acylating agents, alkylating agents, and nitrogen mustards by developing a color (in fact, one of its first applications was the detection of mustard gas). Here, NBP has been used in a simple, colorimetric high-throughput assay, which can be used to screen thousands of clones toward styrene Journal of Biomolecular Screening 9(2); 2004 FIG. 2. Colorimetric NBP assay for epoxides. P450 BM-3 139-3 catalyzes the oxidation of styrene to styrene oxide, which reacts with NBP. The resulting purple dye can be monitored spectrophotometrically. epoxidation. This method will allow us to identify biocatalysts with enhanced coupling and turnover rates and should be generally useful for assaying epoxides in complex biological mixtures.
